rs183951730

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003919.3(SGCE):​c.1253+814G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00867 in 163,474 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0087 ( 8 hom., cov: 31)
Exomes 𝑓: 0.0084 ( 1 hom. )

Consequence

SGCE
NM_003919.3 intron

Scores

1
1
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.504

Publications

1 publications found
Variant links:
Genes affected
SGCE (HGNC:10808): (sarcoglycan epsilon) This gene encodes the epsilon member of the sarcoglycan family. Sarcoglycans are transmembrane proteins that are components of the dystrophin-glycoprotein complex, which link the actin cytoskeleton to the extracellular matrix. Unlike other family members which are predominantly expressed in striated muscle, the epsilon sarcoglycan is more broadly expressed. Mutations in this gene are associated with myoclonus-dystonia syndrome. This gene is imprinted, with preferential expression from the paternal allele. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. A pseudogene associated with this gene is located on chromosome 2. [provided by RefSeq, Oct 2016]
CASD1 (HGNC:16014): (CAS1 domain containing 1) Enables N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity. Involved in carbohydrate metabolic process. Is integral component of Golgi membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01735276).
BP6
Variant 7-94597961-C-T is Benign according to our data. Variant chr7-94597961-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 586562.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00869 (1315/151318) while in subpopulation NFE AF = 0.0127 (864/67856). AF 95% confidence interval is 0.012. There are 8 homozygotes in GnomAd4. There are 609 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 1315 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003919.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SGCE
NM_003919.3
MANE Select
c.1253+814G>A
intron
N/ANP_003910.1
SGCE
NM_001099401.2
c.1297G>Ap.Asp433Asn
missense
Exon 10 of 12NP_001092871.1
SGCE
NM_001346713.2
c.1361+814G>A
intron
N/ANP_001333642.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SGCE
ENST00000648936.2
MANE Select
c.1253+814G>A
intron
N/AENSP00000497130.1
SGCE
ENST00000428696.7
TSL:1
c.1205+814G>A
intron
N/AENSP00000397536.3
SGCE
ENST00000447873.6
TSL:1
c.1226+814G>A
intron
N/AENSP00000388734.1

Frequencies

GnomAD3 genomes
AF:
0.00870
AC:
1315
AN:
151208
Hom.:
8
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00399
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.00870
Gnomad ASJ
AF:
0.0144
Gnomad EAS
AF:
0.00213
Gnomad SAS
AF:
0.00567
Gnomad FIN
AF:
0.00289
Gnomad MID
AF:
0.0255
Gnomad NFE
AF:
0.0127
Gnomad OTH
AF:
0.0130
GnomAD2 exomes
AF:
0.00609
AC:
19
AN:
3120
AF XY:
0.00894
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00718
Gnomad ASJ exome
AF:
0.0116
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00730
Gnomad OTH exome
AF:
0.0116
GnomAD4 exome
AF:
0.00839
AC:
102
AN:
12156
Hom.:
1
Cov.:
0
AF XY:
0.00861
AC XY:
73
AN XY:
8480
show subpopulations
African (AFR)
AF:
0.0174
AC:
3
AN:
172
American (AMR)
AF:
0.00664
AC:
4
AN:
602
Ashkenazi Jewish (ASJ)
AF:
0.0211
AC:
6
AN:
284
East Asian (EAS)
AF:
0.00
AC:
0
AN:
392
South Asian (SAS)
AF:
0.00433
AC:
5
AN:
1156
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
588
Middle Eastern (MID)
AF:
0.0139
AC:
2
AN:
144
European-Non Finnish (NFE)
AF:
0.00926
AC:
77
AN:
8318
Other (OTH)
AF:
0.0100
AC:
5
AN:
500
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00869
AC:
1315
AN:
151318
Hom.:
8
Cov.:
31
AF XY:
0.00824
AC XY:
609
AN XY:
73896
show subpopulations
African (AFR)
AF:
0.00398
AC:
164
AN:
41232
American (AMR)
AF:
0.00869
AC:
132
AN:
15192
Ashkenazi Jewish (ASJ)
AF:
0.0144
AC:
50
AN:
3464
East Asian (EAS)
AF:
0.00214
AC:
11
AN:
5146
South Asian (SAS)
AF:
0.00567
AC:
27
AN:
4760
European-Finnish (FIN)
AF:
0.00289
AC:
30
AN:
10366
Middle Eastern (MID)
AF:
0.0274
AC:
8
AN:
292
European-Non Finnish (NFE)
AF:
0.0127
AC:
864
AN:
67856
Other (OTH)
AF:
0.0129
AC:
27
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
58
116
175
233
291
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00974
Hom.:
2
Bravo
AF:
0.00900
TwinsUK
AF:
0.0138
AC:
51
ALSPAC
AF:
0.0161
AC:
62
ExAC
AF:
0.00458
AC:
48
Asia WGS
AF:
0.00520
AC:
18
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SGCE: BP4, BS1, BS2

not specified Benign:1
Dec 07, 2023
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Myoclonic dystonia 11 Benign:1
Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
2.8
DANN
Uncertain
1.0
Eigen
Benign
-0.72
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.0034
N
LIST_S2
Benign
0.63
T
MetaRNN
Benign
0.017
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.50
PROVEAN
Benign
-0.040
N
REVEL
Benign
0.029
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.51
T
Vest4
0.065
MVP
0.32
MPC
0.19
ClinPred
0.068
T
GERP RS
0.11
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs183951730; hg19: chr7-94227273; API